Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_assertion type Assertion NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_head.
- NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_assertion description "[These results suggested that CTLA-4 +49 A/G polymorphism does not contribute to susceptibility to HSP; however, the presence of CTLA-4 AG genotype and HLA-DRB1*13 could be a risk factor for developing nephrotic-range proteinuria in these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_provenance.
- NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_assertion evidence source_evidence_literature NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_provenance.
- NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_assertion SIO_000772 18449568 NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_provenance.
- NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_assertion wasDerivedFrom befree-2016 NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_provenance.
- NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_assertion wasGeneratedBy ECO_0000203 NP668767.RAgDo2s1G0eYtgVfqexnhT6lXXnO5znI7kRN431Pn0HU8130_provenance.